Daunorubitec 20 mg Injection
$4.49
$3.70
Daunorubitec 20 mg Injection is a vital immunosuppressant used in the treatment of acute leukemia, specifically targeting conditions such as acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) in pediatric patients. This medication operates by effectively targeting and obliterating the malignant white blood cells that characterize these types of blood cancers, thereby aiding in the restoration of healthier cell levels. Administered in conjunction with other therapeutic agents, Daunorubitec plays a crucial role in comprehensive leukemia management. It is important to note that this injection may lead to significant side effects, including increased susceptibility to infections due to its immunosuppressive properties. Healthcare providers must monitor patients closely for any adverse reactions during treatment. As with any cancer treatment, discussing potential risks and benefits with a healthcare professional is essential for optimal care. By understanding the mechanisms and effects of Daunorubitec 20 mg Injection, patients and families can make informed decisions in their fight against leukemia.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Daunorubitec 20 mg injection is primarily used in the treatment of acute leukaemia. This type of cancer affects the blood and bone marrow, leading to an overproduction of abnormal white blood cells. By administering Daunorubitec, healthcare providers aim to target and reduce these malignant cells. This helps restore normal blood cell function and improve patient outcomes.
• The medication is effective for both acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML). In cases of ALL, Daunorubitec 20 mg injection works by interfering with the growth and spread of cancer cells. Similarly, for AML patients, it helps to manage the rapid proliferation of myeloid cells. This targeted approach contributes to better disease management and enhances the chances of remission.
• Daunorubitec 20 mg injection is often utilized in combination with other chemotherapy agents. This combination therapy can enhance the effectiveness of treatment by attacking cancer cells through different mechanisms. The use of Daunorubitec in such regimens helps to maximize the therapeutic impact on leukaemia. Physicians frequently tailor these combinations based on individual patient needs and response.
• In clinical settings, Daunorubitec 20 mg injection may be administered during induction therapy. This phase aims to rapidly reduce the number of leukaemia cells in the patient's body. By incorporating Daunorubitec, doctors can initiate a more aggressive treatment approach that is crucial for achieving early remission. The timely use of this injection can significantly influence the overall treatment strategy for acute leukaemia patients.
Benefits
Acute leukemia: Acute leukemia is a type of cancer that starts in the bone marrow, the soft, spongy tissue found inside bones where blood cells are produced. It is characterized by the rapid growth of abnormal white blood cells, which are responsible for fighting infections. Daunorubitec 20 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute lymphocytic blood cancer: Acute Lymphoblastic Leukemia (ALL), also known as acute lymphocytic leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the rapid and uncontrolled growth of immature white blood cells called lymphoblasts or lymphocytes. Daunorubitec 20 mg Vial kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute myeloid blood cancer: Acute Myeloid Leukemia (AML), also known as acute myelogenous leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the rapid and uncontrolled growth of abnormal myeloid cells, which are responsible for producing red blood cells, white blood cells, and platelets. Daunorubitec 20 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Side Effects
Like all medicines, this Daunorubitec Injection can cause side effects, although not everybody gets them. If you are worried about side effects, you should discuss them with your doctor.
Most Common Side Effects
• Pain
• Hair loss
• Mouth sores
• Throat pain
• Hematuria ( Red discolouration of urine
• blood in urine)
• Weight gain
• Tiredness
• Pale skin
• Cold extremities (hands and feet)
• Chills
• Diarrhoea
• Nausea
• Vomiting
• Fever
Common Side Effects
• Shortness of breath
• Irregular Heartbeats ( Cardiac Arrhythmias)
• Low blood counts
• AKI (Acute kidney injury)
• It may include symptoms like no adequate amount of urine or no urine, pedal oedema ( swelling in feet or ankles)
• Liver Injury
• Pain in the stomach, loss of appetite, jaundice ( yellowish of the skin and eyes), clay-coloured stool
How To Use
Your physician or nurse will give you this medicine. Kindly do not self-administer.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Daunorubitec 20 mg Vial. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Daunorubitec 20 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Daunorubitec 20 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Daunorubitec Injection. Daunorubitec 20 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Daunorubitec 20 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Daunorubitec 20 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Daunorubitec 20 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Daunorubitec Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Daunorubitec Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Daunorubitec 20 mg Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Daunorubicin Injection 20 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Anti-cancer Drug Daunorubitec.